Activity of rat UGT1A1 towards benzo[a]pyrene phenols and dihydrodiols

被引:3
作者
Webb, L [1 ]
Miles, K [1 ]
Kessler, F [1 ]
Ritter, JK [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
UDP-glucuronosyltransferase; benzo[a]pyrene; glucuronidation; environmental carcinogenesis;
D O I
10.1016/j.etap.2005.07.018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Four UDP-glucuronosyltransferases from the rat UGT1A family were tested for activity towards benzo[a]pyrene pyenols and dihydrodiols. UGTIA1 and UGTI1A7 were found to be broadly active towards BaP metabolites. Antisera recognizing rat UGT1A1 and UGT1A7 were used to assess UGT levels in relation to UGT activity towards benzo[a]pyrene-7.8-dihydrodiol (BPD). The rank BPD UGT activities were liver=intestine kidney, whereas UGT1A1 was highest in liver and UGT1A7 was highest in intestine. Phenobarbital, an inducer of hepatic UGT1A1, only slightly increased BPD UGT activity, whereas UGT1A7 inducers more potently increased the activity. Inhibition studies using the differential UGTIAI inhibitor, bilirubin, suggest that UGT1A1 is not a major contributor to the constitutive BPD glucuronidating activity of control rat liver microsomes. These data suggest that multiple UGT1A enzymes contribute to glucuronidation of BPD and other BaP metabolites, and that their relative contributions depend on tissue- and environmental-specific factors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [41] Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes
    Lv, Xia
    Hou, Jie
    Xia, Yang-Liu
    Ning, Jing
    He, Gui-Yuan
    Wang, Ping
    Ge, Guang-Bo
    Xiu, Zhi-Long
    Yang, Ling
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (05) : 358 - 365
  • [42] UGT1A1 and UGT1A3 activity and inhibition in human liver and intestinal microsomes and a recombinant UGT system under similar assay conditions using selective substrates and inhibitors
    Mullapudi, T. V. Radhakrishna
    Ravi, Punna Rao
    Thipparapu, Ganapathi
    XENOBIOTICA, 2021, 51 (11) : 1236 - 1246
  • [43] The relationship between UGT1A1 gene & various diseases and prevention strategies
    Liu, Dan
    Yu, Qi
    Ning, Qing
    Liu, Zhongqiu
    Song, Jie
    DRUG METABOLISM REVIEWS, 2022, 54 (01) : 1 - 21
  • [44] UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia
    Skierka, Jennifer M.
    Kotzer, Katrina E.
    Lagerstedt, Susan A.
    O'Kane, Dennis J.
    Baudhuin, Linnea M.
    JOURNAL OF PEDIATRICS, 2013, 162 (06) : 1146 - U107
  • [45] Establishment of the experimental procedure for prediction of conjugation capacity in mutant UGT1A1
    Takaoka, Yutaka
    Takeuchi, Atsuko
    Sugano, Aki
    Miura, Kenji
    Ohta, Mika
    Suzuki, Takashi
    Kobayashi, Daisuke
    Kimura, Takuji
    Sato, Juichi
    Ban, Nobutaro
    Nishio, Hisahide
    Sakaeda, Toshiyuki
    PLOS ONE, 2019, 14 (11):
  • [46] The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
    Bogacz, Anna
    Kaminski, Adam
    Lochynska, Malgorzata
    Uzar, Izabela
    Goracy, Jaroslaw
    Kotrych, Daniel
    Seremak-Mrozikiewicz, Agnieszka
    Czerny, Boguslaw
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells
    Sun, Hua
    Zhou, Xiaotong
    Wu, Baojian
    XENOBIOTICA, 2015, 45 (11) : 945 - 953
  • [48] The clinical application of UGT1A1 pharmacogenetic testing: Gene– environment interactions
    Marques S.C.
    Ikediobi O.N.
    Human Genomics, 4 (4) : 238 - 249
  • [49] Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis
    Zhan, Zhikun
    Dai, Fahong
    Zhang, Tao
    Chen, Yulian
    She, Jianglian
    Jiang, Huanguo
    Liu, Shuwen
    Gu, Tanwei
    Tang, Lan
    PHARMACOLOGICAL RESEARCH, 2022, 178
  • [50] Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia
    Sugatani, J
    Yamakawa, K
    Yoshinari, K
    Machida, T
    Takagi, H
    Mori, M
    Kakizaki, S
    Sueyoshi, T
    Negishi, M
    Miwa, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (02) : 492 - 497